Journal article
Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin
Abstract
The 57-amino acid Kunitz Protease Inhibitor (KPI) domain of Protease Nexin 2 inhibits Factor XIa (FXIa) and other proteases. We previously fused KPI to human serum albumin (KPIHSA). KPIHSA inhibits coagulation Factor XIa (FXIa) 6-fold more rapidly than plasmin. We screened a bacterial expression library of KPI variants randomized at M17, and selected M17D as having the highest anti-FXIa: antiplasmin activity ratio. Expressed as HSA fusion …
Authors
Eltringham-Smith LJ; Bhakta V; Sheffield WP
Journal
Journal of Biotechnology, Vol. 330, , pp. 61–69
Publisher
Elsevier
Publication Date
3 2021
DOI
10.1016/j.jbiotec.2021.02.016
ISSN
0168-1656